Optimizing Antibiotic Choice, Administration, and Duration in NSTI Treatment

Area of Science:

• Infectious Diseases
• Microbiology
• Surgical Infections

Background:

• Necrotizing soft tissue infections (NSTIs) are severe bacterial or fungal infections.
• These infections lead to significant patient morbidity and mortality.
• Early surgical debridement and antibiotic therapy are critical for survival.

Purpose of the Study:

• To categorize NSTIs based on causative pathogens.
• To outline current antimicrobial strategies for NSTIs.
• To emphasize the importance of microbiological data in treatment decisions.

Main Methods:

• Classification of NSTIs into four types based on microbiology: polymicrobial (Type I), monomicrobial (Type II), Gram-negative (Type III), and fungal (Type IV).
• Review of common antimicrobial regimens, including broad-spectrum agents like vancomycin, linezolid, and piperacillin/tazobactam.
• Consideration of patient-specific factors and adjunct therapies like IVIG and clindamycin for toxin suppression.

Main Results:

• NSTIs can be caused by diverse pathogens, including bacteria (aerobic, anaerobic, Gram-negative) and fungi.
• Initial empirical therapy often involves broad-spectrum antibiotics targeting common pathogens.
• Optimizing antimicrobial selection requires consideration of patient factors and microbiological findings.

Conclusions:

• Prompt diagnosis and management, including surgery and antibiotics, are essential for NSTIs.
• Tailoring antibiotic therapy based on microbiological data improves treatment efficacy.
• Adjunct therapies may enhance outcomes in severe NSTIs.